Holen Sie sich die Stockscreener-App
64.40
2.42%
-1.60
Handel nachbörslich:
65.00
0.60
+0.93%
Schlusskurs vom Vortag:
$66.00
Offen:
$65.44
24-Stunden-Volumen:
335.42K
Relative Volume:
2.71
Marktkapitalisierung:
$836.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+42.64%
1M Leistung:
+32.54%
6M Leistung:
+75.81%
1J Leistung:
+0.00%
1-Tages-Spanne:
$55.88
$65.64
1-Wochen-Bereich:
$42.23
$73.59
52-Wochen-Spanne:
$15.19
$73.59
Neurogene Inc Stock (NGNE) Company Profile
Firmenname
Neurogene Inc
Sektor
Branche
Telefon
(877) 237-5020
Adresse
535 W 24TH STREET, NEW YORK
Neurogene Inc Aktie (NGNE) Neueste Nachrichten
Neurogene (NASDAQ:NGNE) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Neurogene Secures $200M for Genetic Therapy Development - Yahoo Finance
Neurogene Announces Oversubscribed $200 Million Private Placement - BioSpace
Neurogene Reaches 52-Week High on $200M Private Placement - MarketWatch
U.S. stock market: Glatfelter soars 1,106.32%, Nuwellis jumps 114.71%, and Staffing 360 Solutions rises 72.94% in significant midday market gains - Business Upturn
Neurogene secures $200 million in oversubscribed PIPE financing By Investing.com - Investing.com South Africa
Neurogene secures $200M ahead of anticipated study readout - BioPharma Dive
Neurogene (NASDAQ:NGNE) Hits New 1-Year HighHere's Why - MarketBeat
Neurogene secures $200 million in oversubscribed PIPE financing - Investing.com
Neurogene Inc. announced that it expects to receive $199.999935 million in funding from a group of investors - Marketscreener.com
Neurogene (NASDAQ:NGNE) Trading Down 3.7%Here's What Happened - MarketBeat
Short Interest in Neurogene Inc. (NASDAQ:NGNE) Drops By 50.8% - MarketBeat
Analysts Set Neurogene Inc. (NASDAQ:NGNE) PT at $51.00 - MarketBeat
Neurogene (NASDAQ:NGNE) Stock Price Down 4.4%Time to Sell? - MarketBeat
Neurogene to Present Interim Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome - Business Wire
Neurogene (NASDAQ:NGNE) Hits New 12-Month HighWhat's Next? - MarketBeat
Neurogene stock holds steady from BMO Capital By Investing.com - Investing.com UK
Marshall Wace LLP Purchases 11,229 Shares of Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Neurogene (NASDAQ:NGNE) Trading Up 4.2% - MarketBeat
Renaissance Technologies LLC Has $1.92 Million Position in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neurogene (NASDAQ:NGNE) Stock Price Down 3.4% - MarketBeat
Neurogene (NASDAQ:NGNE) Sees Unusually-High Trading Volume - MarketBeat
Neurogene's SWOT analysis: gene therapy stock shows promise amid risks - Investing.com
Driehaus Capital Management LLC Has $3.72 Million Stock Holdings in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Neurogene's SWOT analysis: gene therapy stock shows promise amid risks By Investing.com - Investing.com UK
Neurogene Inc. (NASDAQ:NGNE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Rhumbline Advisers Invests $491,000 in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Neurogene (NASDAQ:NGNE) Trading Up 8.2% - MarketBeat
Closing Bell Recap: Neurocrine Biosciences, Inc. (NBIX) Ends at 116.49, Reflecting a -1.07 Downturn - The Dwinnex
Nebius to invest more than USD 1 billion to build AI infrastructure in Europe - sharewise
Renaissance Technologies LLC Raises Holdings in N-able, Inc. (NYSE:NABL) - Defense World
XTX Topco Ltd Sells 4,464 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World
Rhumbline Advisers Has $721,000 Stock Holdings in NETGEAR, Inc. (NASDAQ:NTGR) - Defense World
Raffles Associates LP Has $3.36 Million Holdings in NB Bancorp, Inc. (NASDAQ:NBBK) - Defense World
BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING - WV News
NetApp, Inc. (NASDAQ:NTAP) Shares Sold by American Century Companies Inc. - Defense World
Integral Health Asset Management LLC Buys New Shares in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
70,000 Shares in Neurogene Inc. (NASDAQ:NGNE) Purchased by Integral Health Asset Management LLC - Defense World
NTAP (Netapp Inc) may reap gains as insiders became active recently - Knox Daily
1832 Asset Management L.P. Increases Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World
Ensign Peak Advisors Inc Increases Holdings in NetApp, Inc. (NASDAQ:NTAP) - Defense World
Avoro Capital Advisors LLC Makes New Investment in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Hollencrest Capital Management Buys New Stake in NetApp, Inc. (NASDAQ:NTAP) - Defense World
NetApp, Inc. (NASDAQ:NTAP) Shares Sold by Amalgamated Bank - Defense World
Bank of New York Mellon Corp Purchases New Stake in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Bank of New York Mellon Corp Takes $1.11 Million Position in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
(NBIX) Trading Advice - Stock Traders Daily
Promethos Capital LLC Invests $107,000 in NetApp, Inc. (NASDAQ:NTAP) - Defense World
10,295 Shares in Neuberger Berman Next Generation Connectivity Fund Inc. (NYSE:NBXG) Purchased by Carolinas Wealth Consulting LLC - Defense World
2,056 Shares in NetApp, Inc. (NASDAQ:NTAP) Purchased by Waterloo Capital L.P. - Defense World
Quest Partners LLC Invests $55,000 in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Finanzdaten der Neurogene Inc-Aktie (NGNE)
Es liegen keine Finanzdaten für Neurogene Inc (NGNE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):